Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $akba

Akebia Therapeutics ($AKBA) sees a surge in social media buzz, with creators and mentions up significantly. Recent posts highlight potential investment opportunities and community enthusiasm, despite some market volatility concerns.

### About $akba
Akebia Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutics for patients with kidney diseases.  

### Insights
- $akba sentiment is up XXXXXX% from the previous week.
- $akba creators is up XXXXX% from the previous month.
- $akba mentions is up XXXX% from the previous month.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$akba/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$akba/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +58%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-11-07  
1-Year Low: X on 2025-09-21  

Engagements by network (24h):
Reddit: XX
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$akba/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$akba/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +47%  
X Month: XXX +96%  
X Months: XXXXX +377%  
X Year: XXXXX -XX%  
1-Year High: XXXXX on 2025-06-27  
1-Year Low: X on 2025-09-14  

Mentions by network (24h):
Reddit: X
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$akba/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$akba/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $akba in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX  
X Week: XXX +38%  
X Month: XXX +88%  
X Months: XXXXX +476%  
X Year: XXXXX +396%  
1-Year High: XXX on 2025-06-27  
1-Year Low: X on 2025-09-14  

The most influential creators that mention $akba in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@AscendingBio](/creator/twitter/AscendingBio) | X    | XXX       | X     | XX          |

[View More](/list/creators/$akba/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$akba/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$akba/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +70%  
X Month: XXX% no change  
X Months: XXX% +8%  
X Year: XXX% no change  
1-Year High: XXX% on 2024-12-10  
1-Year Low: XX% on 2025-11-25  

Most Supportive Themes:
- Community Enthusiasm: (60%) Positive sentiment regarding project developments and future potential.
  
Most Critical Themes:
- Market Volatility: (20%) Concerns about price fluctuations and market uncertainty.
  

### Top $akba Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Money Tuesday Watchlist Pt. X $QH $BQ $MVIS $AKBA $M Tomorrow Let's Find Another 500%+ Run"  
[X Link](https://x.com/MorningMadness4/status/1998227888630337670) [@MorningMadness4](/creator/x/MorningMadness4) 2025-12-09T03:07Z 2457 followers, XXX engagements


"$akba $akt Guys Don't miss the next move in a few hours 💸➡"  
[X Link](https://x.com/CaitlinPyke39/status/1997542180651733360) [@CaitlinPyke39](/creator/x/CaitlinPyke39) 2025-12-07T05:42Z XX followers, XX engagements


"$ONDS 🔥Major Money Deals Incoming🔥 $SATL $RDW $CYDY $ATYR $SEZL $ORGO $NAGE $TIGR $XERS $REAL $REVG $POET $ARQT $TDUP $PRCH $EOSE $AMLX $NN $OPFI $ASM $CYFRF $STIM $BCRX $AKBA $OLO $TVTX $SEI $EVER $HCSG $TRVI $DEFTF $NOK $SPX $MSOS $RGLS $CYCN $ZETA"  
[X Link](https://x.com/Newbie_AAA/status/1996633024214212724) [@Newbie_AAA](/creator/x/Newbie_AAA) 2025-12-04T17:29Z XX followers, XXX engagements


"$AKBA Why acquire ADX-097 given the expenses Here is what I expect them to convey related to funding: We want to continue developing new kidney disease drugs. At this junction we do not have large amounts of capital. ADX-097 was sold to us at a low price. Research expenses will be modest in 2026. What helps keep those expenses low is that the FDA does not require large sample sizes for rare diseases. This drug may have some application to conditions that are not rare but that will not be our initial focus"  
[X Link](https://x.com/AscendingBio/status/1995528889750438058) [@AscendingBio](/creator/x/AscendingBio) 2025-12-01T16:22Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$akba

Akebia Therapeutics ($AKBA) sees a surge in social media buzz, with creators and mentions up significantly. Recent posts highlight potential investment opportunities and community enthusiasm, despite some market volatility concerns.

About $akba

Akebia Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutics for patients with kidney diseases.

Insights

  • $akba sentiment is up XXXXXX% from the previous week.
  • $akba creators is up XXXXX% from the previous month.
  • $akba mentions is up XXXX% from the previous month.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +58%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-11-07
1-Year Low: X on 2025-09-21

Engagements by network (24h): Reddit: XX X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +47%
X Month: XXX +96%
X Months: XXXXX +377%
X Year: XXXXX -XX%
1-Year High: XXXXX on 2025-06-27
1-Year Low: X on 2025-09-14

Mentions by network (24h): Reddit: X X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $akba in the last XX hours which is up XX% from X in the previous XX hours Daily Average: XX
X Week: XXX +38%
X Month: XXX +88%
X Months: XXXXX +476%
X Year: XXXXX +396%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-14

The most influential creators that mention $akba in the last XX hours

Creator Rank Followers Posts Engagements
@AscendingBio X XXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +70%
X Month: XXX% no change
X Months: XXX% +8%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-10
1-Year Low: XX% on 2025-11-25

Most Supportive Themes:

  • Community Enthusiasm: (60%) Positive sentiment regarding project developments and future potential.

Most Critical Themes:

  • Market Volatility: (20%) Concerns about price fluctuations and market uncertainty.

Top $akba Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Money Tuesday Watchlist Pt. X $QH $BQ $MVIS $AKBA $M Tomorrow Let's Find Another 500%+ Run"
X Link @MorningMadness4 2025-12-09T03:07Z 2457 followers, XXX engagements

"$akba $akt Guys Don't miss the next move in a few hours 💸➡"
X Link @CaitlinPyke39 2025-12-07T05:42Z XX followers, XX engagements

"$ONDS 🔥Major Money Deals Incoming🔥 $SATL $RDW $CYDY $ATYR $SEZL $ORGO $NAGE $TIGR $XERS $REAL $REVG $POET $ARQT $TDUP $PRCH $EOSE $AMLX $NN $OPFI $ASM $CYFRF $STIM $BCRX $AKBA $OLO $TVTX $SEI $EVER $HCSG $TRVI $DEFTF $NOK $SPX $MSOS $RGLS $CYCN $ZETA"
X Link @Newbie_AAA 2025-12-04T17:29Z XX followers, XXX engagements

"$AKBA Why acquire ADX-097 given the expenses Here is what I expect them to convey related to funding: We want to continue developing new kidney disease drugs. At this junction we do not have large amounts of capital. ADX-097 was sold to us at a low price. Research expenses will be modest in 2026. What helps keep those expenses low is that the FDA does not require large sample sizes for rare diseases. This drug may have some application to conditions that are not rare but that will not be our initial focus"
X Link @AscendingBio 2025-12-01T16:22Z XXX followers, XXX engagements

$akba
/topic/$akba